Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Conjugated Linoleic Acid (c9, t11-CLA).
Conjugated Linoleic Acid acts as a dual ligand for PPAR-alpha and PPAR-gamma receptors, modulating lipid metabolism and inhibiting lipoprotein lipase activity to reduce adipocyte volume and improve body composition.
5280644
280.4 g/mol
7.1
(9Z,11E)-octadeca-9,11-dienoic acid
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Conjugated Linoleic Acid (c9, t11-CLA) across standard consumer modalities.
As a liquid lipid, CLA requires encapsulation in softgel shells or conversion to a microencapsulated powder to prevent oxidation and leakage in standard two-piece hard capsules.
High lipid concentrations in gummy formulations often lead to emulsion instability, resulting in oil migration to the surface and compromised structural integrity of the pectin or gelatin matrix.
The high therapeutic dosage requirements (typically 1-3 grams) far exceed the payload capacity of thin-film polymers, which are generally limited to sub-100mg active ingredients.
Ready to launch a product featuring Conjugated Linoleic Acid (c9, t11-CLA)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Conjugated Linoleic Acid (c9, t11-CLA) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Conjugated Linoleic Acid (c9, t11-CLA) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation